SLGT2i for Neuroprotection in Patients With Acute Ischemic Stroke
NCT07105917
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
1050
Enrollment
OTHER
Sponsor class
Conditions
Acute Ischemic Stroke
Interventions
DRUG:
SGLT-2 inhibitors
OTHER:
Standard medical treatment
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University